$0.595500
0.011.76%
Last update: 11:34 AM
15 minutes delayed
Comments
Loading...
Gritstone Bio (GRTS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGritstone Bio (NASDAQ:GRTS) Stock Quotes, Forecast and News Summary
Gritstone Bio Stock (NASDAQ: GRTS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gritstone Bio (GRTS) stock?
You can purchase shares of Gritstone Bio (NASDAQ:GRTS) through any online brokerage.
Who are Gritstone Bio (GRTS) competitors?
Other companies in Gritstone Bio’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB) and OS Therapies (AMEX:OSTX).
What is the forecast, or price target, for Gritstone Bio (GRTS) stock?
Gritstone Bio has a consensus price target of $4.20.
What is the current price for Gritstone Bio (GRTS)?
The stock price for Gritstone Bio (NASDAQ: GRTS) is $0.5955 last updated September 25, 2024 at 11:34 AM EDT.
Does Gritstone Bio (GRTS) pay a dividend?
There are no upcoming dividends for Gritstone Bio.
When is Gritstone Bio (NASDAQ:GRTS) reporting earnings?
Gritstone Bio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Gritstone Bio (GRTS) going to split?
There is no upcoming split for Gritstone Bio.
What sector and industry does Gritstone Bio (GRTS) operate in?
Gritstone Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.